secwatch.observer — SEC 8-K summary
======================================

Issuer:     Valion Bio, Inc. (VBIO)
CIK:        0001787740
Form:       8-K
Filed at:   2023-08-09T23:59:59+00:00
Accession:  0000950170-23-040603
Event type: other_material
Sentiment:  negative
Materiality: 0.75
Item codes: 1.01, 3.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Tivic Health prices $1.4M public offering of 33.2M shares at $0.041/share
-------------------------------------------------------------------------

- Priced public offering of 33,173,000 shares at $0.041/share; expected gross proceeds ~$1.4M.
- Net proceeds ~$1.2M after placement agent fees and expenses; use for working capital and general corporate purposes.
- Maxim Group LLC acted as sole placement agent; received 8% cash fee ($108,807) and warrants for 1,326,920 shares at $0.0492.
- Offering closed on August 9, 2023; officers and directors entered 30-day lock-up agreements.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1787740/000095017023040603/0000950170-23-040603-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1787740/000095017023040603/tivc-20230806.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-040603

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer